Status:
COMPLETED
Evaluation of Patients With Covid-19 Infection in Terms of Severity of Osteoprosis
Lead Sponsor:
Kayseri Education and Research Hospital
Conditions:
Severity of Osteoprosis
Eligibility:
FEMALE
18-100 years
Brief Summary
Osteoporosis is a condition characterized by decreased bone strength and an increased risk of fracture. Age, gender, body mass index, fragility fracture history, corticosteroid use, immobilization, sm...
Eligibility Criteria
Inclusion
- Female patients over the age of 18 who had dexa measurements twice before and after covid, with at least one year between two dexa measurements, and at least one month after covid infection were included in the study.
Exclusion
- Under the age of 18, male patients, patients with a diagnosis other than Covid-19 infection that will affect bone metabolism between the two dexa shooting dates before and after covid, patients who use another drug other than covid treatment that will affect bone metabolism between the two dexa shooting dates before and after covid not included in the study
Key Trial Info
Start Date :
January 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 15 2022
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT05993130
Start Date
January 15 2021
End Date
December 15 2022
Last Update
August 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kayseri City Hospital
Kayseri, Turkey (Türkiye)